|
|
Services as Directors of Blu Label Unlimited Group Limited R’000 |
Services as Directors of subsidiaries of Blu Label Unlimited Group Limited R’000 |
Salary and allowances from subsidiaries R’000 |
Bonuses and performance- related payments R’000 |
Total R’000 |
Fair value of conditional shares R’000 |
| FOR THE YEAR ENDED 31 MAY 2026 |
|
|
|
|
|
|
| EXECUTIVE DIRECTORS |
|
|
|
|
|
|
| BM Levy |
– |
– |
12 900 |
7 730 |
20 630 |
33 059 |
| MS Levy |
– |
– |
12 900 |
7 730 |
20 630 |
33 059 |
| DA Suntup1 |
– |
– |
6 832 |
5 3641 |
12 196 |
17 509 |
|
– |
– |
32 632 |
20 824 |
53 456 |
83 627 |
| NON-EXECUTIVE DIRECTORS |
|
|
|
|
|
|
| LM Nestadt**** |
3 115 |
– |
– |
– |
3 115 |
– |
| JS Mthimunye* |
356 |
74 |
– |
– |
430 |
– |
| SJ Vilakazi |
1 584 |
– |
– |
– |
1 584 |
– |
| H Masondo |
1 075 |
– |
– |
– |
1 075 |
– |
| NP Mnxasana |
1 072 |
50 |
– |
– |
1 122 |
– |
| LE Mthimunye |
1 531 |
28 |
– |
– |
1 559 |
– |
| RD Mokhobo** |
897 |
– |
– |
– |
897 |
– |
| LP Ralphs*** |
723 |
– |
– |
– |
723 |
– |
|
10 353 |
152 |
– |
– |
10 505 |
– |
|
10 353 |
152 |
32 632 |
20 824 |
63 961 |
83 627 |
| FOR THE YEAR ENDED 31 MAY 2025 |
| EXECUTIVE DIRECTORS |
| BM Levy |
| MS Levy |
| DA Suntup |
|
| NON-EXECUTIVE DIRECTORS |
| LM Nestadt |
| JS Mthimunye |
| SJ Vilakazi |
| H Masondo |
| NP Mnxasana |
| LE Mthimunye |
|
|
| 1 |
Included in DA Suntup’s bonuses and performance-related payments is a once-off amount of R2.5 million, awarded in recognition of his involvement in the Pre-Listing Restructuring transactions and the subsequent listing of Cell C Holdings Limited on the JSE in November 2025. |
| * |
Resigned on 29 August 2025. |
| ** |
Appointed on 1 October 2025. |
| *** |
Appointed on 24 February 2026. |
| **** |
Resigned effective 26 August 2026. |
The fair value of conditional shares per Director has been included.
No Director has a notice period of more than one year.
No Director’s service contract includes predetermined compensation as a result of termination that would exceed one year’s salary and benefits.
|
Issue date |
Issue price R |
Vesting date |
Awards outstanding as at the beginning of the year |
Number of shares awarded during the year |
Awards forfeited during the year |
Awards vested during the year |
Balance as at the end of the year |
| CONDITIONAL SHARE PLAN |
|
|
|
|
|
|
|
|
| FOR THE YEAR ENDED 31 MAY 2026 |
|
|
|
|
|
|
|
|
| EXECUTIVE DIRECTORS |
|
|
|
|
|
|
|
|
| BM Levy2 |
6 April 2022 |
6.42 |
24 November 2025 |
578 521 |
– |
– |
(578 521) |
– |
| BM Levy2 |
1 September 2022 |
6.25 |
24 November 2025 |
874 878 |
– |
(43 744) |
(831 134) |
– |
| BM Levy |
23 October 2023 |
3.22 |
31 August 2026 |
1 817 001 |
– |
– |
– |
1 817 001 |
| BM Levy3 |
27 November 2025 |
4.93 |
31 August 2027 |
– |
1 257 969 |
– |
– |
1 257 969 |
| BM Levy3 |
28 November 2025 |
12.35 |
31 August 2028 |
– |
522 256 |
– |
– |
522 256 |
|
|
|
|
3 270 400 |
1 780 225 |
(43 744) |
(1 409 655) |
3 597 226 |
| MS Levy2 |
6 April 2022 |
6.42 |
24 November 2025 |
578 521 |
– |
– |
(578 521) |
– |
| MS Levy2 |
1 September 2022 |
6.25 |
24 November 2025 |
874 878 |
– |
(43 744) |
(831 134) |
– |
| MS Levy |
23 October 2023 |
3.22 |
31 August 2026 |
1 817 001 |
– |
– |
– |
1 817 001 |
| MS Levy3 |
27 November 2025 |
4.93 |
31 August 2027 |
– |
1 257 969 |
– |
– |
1 257 969 |
| MS Levy3 |
28 November 2025 |
12.35 |
31 August 2028 |
– |
522 256 |
– |
– |
522 256 |
|
|
|
|
3 270 400 |
1 780 225 |
(43 744) |
(1 409 655) |
3 597 226 |
| DA Suntup2 |
6 April 2022 |
6.42 |
24 November 2025 |
306 407 |
– |
– |
(306 407) |
– |
| DA Suntup2 |
1 September 2022 |
6.25 |
24 November 2025 |
463 369 |
– |
(23 169) |
(440 200) |
– |
| DA Suntup |
23 October 2023 |
3.22 |
31 August 2026 |
962 354 |
– |
– |
– |
962 354 |
| DA Suntup3 |
27 November 2025 |
4.93 |
31 August 2027 |
– |
666 269 |
– |
– |
666 269 |
| DA Suntup3 |
28 November 2025 |
12.35 |
31 August 2028 |
– |
276 607 |
– |
– |
276 607 |
|
|
|
|
1 732 130 |
942 876 |
(23 169) |
(746 607) |
1 905 230 |
| FOR THE YEAR ENDED 31 MAY 2025 |
| EXECUTIVE DIRECTORS |
| BM Levy4 |
| BM Levy |
| BM Levy |
| BM Levy5 |
|
| MS Levy4 |
| MS Levy |
| MS Levy |
| MS Levy5 |
|
| DA Suntup4 |
| DA Suntup |
| DA Suntup |
| DA Suntup5 |
|
| 2 |
As reported in the prior year, the vesting, transfer and/or sale of certain share awards to BM Levy, MS Levy and DA Suntup had been restricted by a closed period in terms of the JSE Listings Requirements. This closed period expired on 24 November 2025. Following its expiry, the shares awarded on 6 April 2022 and 1 September 2022 vested on 24 November 2025 and were transferred to the respective Directors. These shares are accordingly no longer restricted or included in treasury shares at year-end. |
| 3 |
The 2024 and 2025 share awards, which had not previously been allocated to BM Levy, MS Levy and DA Suntup as a consequence of the closed period referred to above, were awarded following its expiry – the 2024 awards on 27 November 2025 and the 2025 awards on 28 November 2025. |
| 4 |
Although 578 521 shares vested to BM Levy and MS Levy and 306 407 shares vested to DA Suntup during the year, the transfer and/or sale of these shares were restricted due to a closed period in terms of the JSE Listings Requirements. The shares will be transferred once the closed period expires. The shares are included in treasury shares and management has concluded that no agency relationship exists over the shares while these rights are restricted. |
| 5 |
The 2024 share awards were not allocated to BM Levy, MS Levy and DA Suntup due to them being placed in a closed period. The shares will be awarded once the closed period expires. |
|